MDxHealth SA MDXH

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $0.71
Market Cap $36.47M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑19.8% YoY
$107.88M
3-Yr CAGR: 42.8%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑83.0% YoY
-$3.35M
FCF Yield: -9.17%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MDXH)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $11.8M $0.0M $-22.3M $-22.4M
FY 2020 $18.5M +56.6% $8.0M $-20.2M $-20.8M +7.1%
FY 2021 $22.2M +20.5% $10.6M 0.00% $-22.5M $-23.4M -12.8%
FY 2022 $37.1M +66.6% $19.2M 0.00% $-34.1M $-36.9M -57.4%
FY 2023 $70.2M +89.4% $43.9M 0.00% $-21.5M $-24.2M +34.3%
FY 2024 $90.0M +28.3% $55.1M 0.00% $-18.5M $-19.7M +18.7%
FY 2025 $107.9M +19.8% $69.6M 0.00% $-2.2M $-3.3M +83.0%
$

Valuation

Market Price $0.71
Market Cap $36.47M
Enterprise Value $7.44M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -9.17%
Dividend Yield 0.00%
Shares Outstanding 51,364,500
%

Profitability & Margins

Gross Margin 64.55%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) N/A
Asset Turnover 0.73x
Revenue 3-Yr CAGR 42.79%
🛡️

Financial Health & Liquidity

Current Ratio 0.30
Cash Ratio 4.31
Debt / Equity -0.000
Debt / Assets 0.000
Cash & Equivalents $29.03M
Total Debt N/A
Book Value / Share $-0.24
💧

Cash Flow Efficiency

Operating Cash Flow -$2.19M
Capital Expenditures (CapEx) $1.16M
Free Cash Flow -$3.35M
OCF / Revenue -2.03%
FCF / Revenue -3.10%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-0.24
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $147.95M
Total Liabilities $160.05M
Stockholders' Equity -$12.09M
Current Assets $2.02M
Current Liabilities $6.74M